(UroToday.com) The 2025 APCCC Diagnostics annual meeting featured a session on how to monitor metastatic prostate cancer and ...

SNS Insider Report Highlights 10.04% CAGR Growth Fueled by Technological Breakthroughs and Rising Global Cancer Burden.Pune, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Tumor Profiling Market Size & Growth ...

Early diagnosis of lung cancer is a critical priority in clinical practice. It may help reduce the rate of ...

Medically reviewed by Marla Anderson, MD Multiple myeloma is a rare type of blood cancer that starts in your plasma cells.

There are currently 82,000 incident cases of RCC annually in the United States (account for 3–5% of cancers), with 15,000 deaths annually in the United States. The overall 5-year mortality risk is ~30 ...

Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.

Background Treatment strategies for Crohn’s disease (CD) suppress diverse inflammatory pathways but many patients remain ...

This condition usually gets worse slowly as the number of blood cells goes up. MDS/MPNs are rare blood cancers that have features of both myelodysplastic disorders and myeloproliferative neoplasms: ...

In the mouse model and human tumor samples, MAGE-4 drives the accumulation of plasma immune cells that suppress antitumor immunity. The study points at novel potential therapeutic avenues that could ...

DelveInsight’s Blastic Plasmacytoid Dendritic Cell Neoplasm Market report offers an in-depth understanding of the epidemiology and market trends in the 7MM. LAS VEGAS, NV, UNITED STATES ...